India · Delayed Price · Currency is INR Colgate-Palmolive (India) Earnings Call Transcripts
Fiscal Year 2026
-
Oral care growth is driven by premiumization, rural penetration, and digital-led innovation, with premium brands outpacing competitors. Financials show strong sales, margin expansion, and increased investment in premiumization, while new launches and partnerships support future growth.
-
Q4 saw 9% sales growth and strong margins, with premiumization and brand investments accelerating. Full-year sales were flat, but H2 improved, and premium brands now drive a larger share. Gross margins are expected to remain stable, with balanced growth between volume and pricing.
Fiscal Year 2025
-
FY2024-25 saw 6.5% revenue growth, strong margins, and robust premiumization, despite a Q4 revenue dip and soft urban demand. Rural and premium segments outperformed, with major product launches and continued high brand investment.
Fiscal Year 2024
-
Growth continues to outpace FMCG peers, driven by strong brand equity, premiumization, and digital-led execution. The Oral Health Movement and innovation in premium products are expanding the market, while financial discipline and ESG remain central.